UK shares slide as inflation, Omicron risks grow
Reuters
Published Dec 02, 2021 08:30
(Reuters) - UK shares fell on Thursday due to fears around the Omicron coronavirus variant, with the United States confirming its first case of the new strain, while warnings about inflation from major central banks further added to the downbeat mood.
The benchmark FTSE 100 index declined 0.8% at 0805 GMT, diverging from its Asian peers, while the domestically focussed mid-cap index fell 0.9%.
Drugmaker GlaxoSmithKline added 0.7% after a pre-clinical analysis of the antibody-based COVID-19 therapy it is developing with U.S. partner Vir indicated that the drug also works against the new Omicron variant.
BoE Governor Andrew Bailey said on Wednesday that the economic impact from COVID-19 still remains strong, while noting the inflationary pressure from supply chain difficulties and increased demand for consumer goods.
Johnson Matthey (LON:JMAT) and Darktrace (LON:DARK) dropped 1.2% and 1.0% respectively after index manager FTSE Russell confirmed that the companies are set to leave Britain's blue-chip FTSE 100 index.
Halfords Group (LON:HFD) Plc rose 5.4% after saying it would buy Axle Group for 62 million pounds ($82.54 million) as the cycle retailer shifts focus to its motoring services business.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.